Guidance
SARS-CoV-2 lateral flow antigen tests: evaluation of VOC1 and VOC2
PHE Porton Down has carried out a rapid assessment on whether lateral flow devices can detect VOC1 and VOC2.
Documents
Details
Working with academic collaborators at the University of Oxford, PHE Porton Down has been evaluating the performance of lateral flow devices (LFDs) since mid-August 2020. Over 80 have been considered to date, approximately 30% of which have progressed to extended evaluation on clinical samples at Phase 3.
Updates to this page
Published 12 February 2021